Additionally, both ageing and cardiovascular comorbidities do affect the immune function, potentially increasing the COVID-19 susceptibility and severity(8). Existing evidence highlights two links between coronavirus infection and cardiovascular disease: 1) patients with symptomatic COVID-19 have cardiovascular comorbidities in a significant percentage of cases(9) and 2) the presence of cardiovascular comorbidities appears to be a risk factor for developing more severe COVID-19(10). However, classifying comorbid cardiovascular diseases (CVDs) in patients with COVID-19 has received little attention. To the best of our knowledge, academic reports regarding clinical features of COVID-19 have not clearly reported cardiovascular disorders in details or valvular pathologies prevalence(11).